@Eric Garcetti via Flickr

Moderna booster shot should provide ‘good level of protection’ against omicron, vaccine maker says

Monday’s data was “very reassuring because we’ve seen time and time again … that the vaccine is highly effective at preventing infection, hospitalization and death due to covid.”

Vaccine manufacturer Moderna said Monday that a booster dose of its coronavirus vaccine significantly raised antibody levels against the omicron variant, amid growing concerns about its rapid spread in the United States, reports the Washington Post.

A booster dose of Moderna’s vaccine — half the dose used in the original shots for adults — increased antibody levels against omicron by 37 times, the company said in a statement, citing preliminary data.

Those antibodies “should provide some good level of protection as we go into the holiday season,” Paul Burton, Moderna’s chief medical officer, said in an interview.

Federal health officials warned this weekend, ahead of Christmas and New Year’s gatherings, that the United States could face record levels of coronavirus cases in the coming days. New York state has for three straight days reported record case numbers, and officials said the country could soon face the same fate.

© Copyright LaPresse

Go to Top